Cargando…

Design and Synthesis of C-Terminal Modified Cyclic Peptides as VEGFR1 Antagonists

Previously designed cyclic peptide antagonist c[YYDEGLEE]-NH(2) disrupts the interaction between vascular endothelial growth factor (VEGF) and its receptors (VEGFRs). It represents a promising tool in the fight against cancer and age-related macular degeneration. We described in this paper the optim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Lei, Gagey-Eilstein, Nathalie, Broussy, Sylvain, Reille-Seroussi, Marie, Huguenot, Florent, Vidal, Michel, Liu, Wang-Qing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6270838/ https://www.ncbi.nlm.nih.gov/pubmed/25264829 http://dx.doi.org/10.3390/molecules191015391

Ejemplares similares

Disrupting VEGF–VEGFR1 Interaction: De Novo Designed Linear Helical Peptides to Mimic the VEGF(13-25) Fragment
por: Balsera, Beatriz, et al.
Publicado: (2017)

Biophysical Studies of the Induced Dimerization of Human VEGF Receptor 1 Binding Domain by Divalent Metals Competing with VEGF-A
por: Gaucher, Jean-François, et al.
Publicado: (2016)

Structural and ITC Characterization of Peptide‐Protein Binding: Thermodynamic Consequences of Cyclization Constraints, a Case Study on Vascular Endothelial Growth Factor Ligands
por: Gaucher, Jean‐François, et al.
Publicado: (2022)

One-pot oxime ligation from peptides bearing thiazolidine and aminooxyacetyl groups
por: Duflocq, Stéphane, et al.
Publicado: (2020)

Phenyloxycarbonyl (Phoc) Carbamate: Chemioselective Reactivity and Tetra-n-butylammonium Fluoride Deprotection Study
por: Huguenot, Florent, et al.
Publicado: (2022)

A Cyclic Peptide Epitope of an Under-Explored VEGF-B Loop 1 Demonstrated In Vivo Anti-Angiogenic and Anti-Tumor Activities
por: Wang, Lei, et al.
Publicado: (2021)

Biochemical mechanism and biological effects of the inhibition of silent information regulator 1 (SIRT1) by EX-527 (SEN0014196 or selisistat)
por: Broussy, Sylvain, et al.
Publicado: (2020)

A Structural Overview of Vascular Endothelial Growth Factors Pharmacological Ligands: From Macromolecules to Designed Peptidomimetics
por: Ye, Xiaoqing, et al.
Publicado: (2021)

Molecular docking, synthesis and biological evaluation of Vascular Endothelial Growth Factor (VEGF) B based peptide as antiangiogenic agent targeting the second domain of the Vascular Endothelial Growth Factor Receptor 1 (VEGFR1D2) for anticancer application
por: Sadremomtaz, Afsaneh, et al.
Publicado: (2020)

A VEGFB-Based Peptidomimetic Inhibits VEGFR2-Mediated PI3K/Akt/mTOR and PLCγ/ERK Signaling and Elicits Apoptotic, Antiangiogenic, and Antitumor Activities
por: Namjoo, Mohadeseh, et al.
Publicado: (2023)

Development of N-Terminally Modified Variants of the CXCR4-Antagonistic Peptide EPI-X4 for Enhanced Plasma Stability
por: Harms, Mirja, et al.
Publicado: (2023)

Novel peptides suppress VEGFR-3 activity and antagonize VEGFR-3-mediated oncogenic effects
por: Chang, Yi-Wen, et al.
Publicado: (2014)

Genetic Encoding and Enzymatic Deprotection of a Latent Thiol Side Chain to Enable New Protein Bioconjugation Applications
por: Reille‐Seroussi, Marie, et al.
Publicado: (2021)

Development and Structural Analysis of a Nanomolar Cyclic Peptide Antagonist for the EphA4 Receptor
por: Lamberto, Ilaria, et al.
Publicado: (2014)

Structure-Based Design of Peptides Targeting VEGF/VEGFRs
por: Di Stasi, Rossella, et al.
Publicado: (2023)

Targeted Discovery of Tetrapeptides and Cyclic Polyketide‐Peptide Hybrids from a Fungal Antagonist of Farming Termites
por: Schalk, Felix, et al.
Publicado: (2020)

Natriuretic peptides modify Pseudomonas fluorescens cytotoxicity by regulating cyclic nucleotides and modifying LPS structure
por: Veron, Wilfried, et al.
Publicado: (2008)

PET Imaging of VEGFR with a Novel (64)Cu-Labeled Peptide
por: Hu, Kuan, et al.
Publicado: (2020)

Mitochondria-targeted Triphenylamine Derivatives Activatable by Two-Photon Excitation for Triggering and Imaging Cell Apoptosis
por: Chennoufi, Rahima, et al.
Publicado: (2016)

Metformin’s Mechanism of Action Is Stimulation of the Biosynthesis of the Natural Cyclic AMP Antagonist Prostaglandylinositol Cyclic Phosphate (Cyclic PIP) †
por: Wasner, Heinrich K.
Publicado: (2022)

In Vitro Selection of Highly Modified Cyclic Peptides That Act as Tight Binding Inhibitors
por: Guillen Schlippe, Yollete V., et al.
Publicado: (2012)

Altered levels of circulating natural antibodies against VEGFR1-derived peptide in atherosclerosis
por: Wang, Peng, et al.
Publicado: (2020)

Stimuli-responsive membrane activity of cyclic-peptide–polymer conjugates
por: Hartlieb, Matthias, et al.
Publicado: (2019)

Designing Cyclic-Constrained Peptides to Inhibit Human Phosphoglycerate Dehydrogenase
por: Qing, Xiaoyu, et al.
Publicado: (2023)

Engineered ligand‐based VEGFR antagonists with increased receptor binding affinity more effectively inhibit angiogenesis
por: Kapur, Shiven, et al.
Publicado: (2017)

Light-controllable dithienylethene-modified cyclic peptides: photoswitching the in vivo toxicity in zebrafish embryos
por: Afonin, Sergii, et al.
Publicado: (2020)

RP S19 C-terminal peptide trimer acts as a C5a receptor antagonist
por: Nishiura, Hiroshi, et al.
Publicado: (2016)

Methionine epimerization in cyclic peptides
por: Jadhav, Pramodkumar D., et al.
Publicado: (2021)

Plant derived cyclic peptides
por: Daly, Norelle L., et al.
Publicado: (2021)

Editorial: Computer-aided drug design: Drug discovery, computational modelling, and artificial intelligence
por: Ye, Fei, et al.
Publicado: (2022)

Superantigen antagonist peptides
por: Llewelyn, Martin, et al.
Publicado: (2001)

Mannan-modified adenovirus targeting TERT and VEGFR-2: A universal tumour vaccine
por: Wang, Ying, et al.
Publicado: (2015)

Termination and activation of store-operated cyclic AMP production
por: Maiellaro, Isabella, et al.
Publicado: (2012)

Structure–Activity Relationship of RGD-Containing Cyclic Octapeptide and αvβ3 Integrin Allows for Rapid Identification of a New Peptide Antagonist
por: Silva, Aaron, et al.
Publicado: (2020)

Agonist/Antagonist Activity of Oxytocin Variants Obtained from Free Cyclic Peptide Libraries Generated via Amino Acid Substitution
por: Kinoshita, Remi, et al.
Publicado: (2021)

A Computational Approach to Modeling an Antagonistic Angiogenic VEGFR1-IL2 Fusion Protein for Cancer Therapy
por: Shafique, Qurrat ul Ain, et al.
Publicado: (2021)

Synthesis and Biological Evaluation of Termini-Modified and Cyclic Variants of the Connexin43 Inhibitor Peptide5
por: Crystal Chan, Sin Hang, et al.
Publicado: (2022)

uPARAP/Endo180 receptor is a gatekeeper of VEGFR-2/VEGFR-3 heterodimerisation during pathological lymphangiogenesis
por: Durré, Tania, et al.
Publicado: (2018)

Association between EGFR/KRAS mutation and expression of VEGFA, VEGFR and VEGFR2 in lung adenocarcinoma
por: Yuan, Xiao-Han, et al.
Publicado: (2018)

Identification of high-affinity VEGFR3-binding peptides through a phage-displayed random peptide library
por: Shi, Li-Feng, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_c1v2u4tr3getcjoajpou874ag6